TLRY
Tilray Inc
NASDAQ: TLRY · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$6.24
+1.63% today
Updated 2026-04-30
Market cap
$784.60M
P/E ratio
—
P/S ratio
0.91x
EPS (TTM)
$-14.63
Dividend yield
—
52W range
$4 – $23
Volume
4.5M
Tilray Inc (TLRY) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-43051.00 | $-41162.00 | $-41162.00 | $-4.38M | $-757620.00 | $-4.48M | $-7.63M | $-62.97M | $-343.77M | $-53.99M | $-177.26M | $7.91M | $-42.11M | $-129.81M |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $2.02M | $3.43M | $659257.00 | $13.87M | $68.34M | $98.23M | $46.94M | $34.06M | $20.80M | $39.85M | $45.17M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $44983.00 | — | — | $1.02M | $354464.00 | $1.78M | $13.86M | $19.28M | $18.08M | $17.35M | $35.99M | $39.59M | $31.77M | $24.29M |
| Free cash flow | $-43051.00 | $-41162.00 | $-41162.00 | $-6.40M | $-4.19M | $-5.14M | $-21.50M | $-131.31M | $-442.00M | $-100.93M | $-211.33M | $-12.89M | $-81.96M | $-174.98M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | $7.48B | $81.44M | — | $1.54M |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — |